Colon cancer metastatic – Diagnostics

Go back

Diagnosing metastatic colon cancer involves a combination of imaging tests, laboratory analysis, and tissue examination to determine where the cancer has spread and guide treatment decisions. Understanding the diagnostic process can help you feel more prepared and informed as you work with your medical team to develop the best care plan for your situation.

Introduction: Who Should Undergo Diagnostics

If you have been treated for colon cancer in the past, or if you are experiencing new or worsening symptoms that suggest cancer may have spread, your doctor will likely recommend diagnostic tests. Metastatic colon cancer, also known as stage 4 colon cancer, means that the disease has spread from where it started in the colon to other parts of the body, most commonly the liver, lungs, or distant lymph nodes.[1]

Sometimes colon cancer doesn’t cause any symptoms, even when it has reached an advanced stage. This is why people who have been treated for colon cancer need regular follow-up appointments and monitoring, even if they feel well. Your doctor may suggest diagnostic tests if you experience symptoms such as pain in your abdomen, blood in your stool, changes in bowel habits, unexplained weight loss, persistent tiredness, shortness of breath, or a cough that won’t go away. Each of these symptoms could indicate that cancer has returned or spread to other areas.[1][6]

It’s also important to know that colorectal cancer can spread very early in the disease process, sometimes long before the original tumor is large enough to be detected by screening tests. Research has shown that in many patients, cancer cells break away from the primary tumor and travel to distant parts of the body early on, which means metastasis can occur even years before a diagnosis is made. This finding highlights the importance of screening and early detection, as well as ongoing monitoring after initial treatment.[3]

If imaging tests or other evaluations suggest that your colon cancer may have spread, your healthcare team will recommend a series of diagnostic procedures to confirm the diagnosis, determine the extent of the spread, and help plan the most appropriate treatment. These tests are essential because they provide detailed information about where the cancer is located, how aggressive it is, and which treatments are most likely to help you.[5]

Diagnostic Methods

Diagnosing metastatic colon cancer requires a combination of different tests and procedures. Each test serves a specific purpose, and together they give your medical team a complete picture of your condition. The main methods used include imaging tests, laboratory blood tests, genetic testing, and tissue biopsies.[9]

Imaging Tests

Imaging tests are the primary tools doctors use to see inside your body and identify areas where cancer may have spread. These tests create detailed pictures of your organs and tissues, allowing doctors to detect tumors and assess their size and location.

CT scans, or computed tomography scans, are one of the most commonly used imaging tests for metastatic colon cancer. A CT scan uses X-rays and computer technology to create cross-sectional images of your body. This test is particularly useful for detecting cancer that has spread to the liver, lungs, or abdominal cavity. During a CT scan, you may be asked to drink a contrast liquid or receive an injection of contrast dye, which helps certain areas show up more clearly on the images.[9]

MRI scans, or magnetic resonance imaging, use powerful magnets and radio waves instead of X-rays to produce detailed images of soft tissues. MRI scans are especially helpful for examining the liver and brain, and they can provide more detailed information than CT scans in certain situations. Like CT scans, MRI may also involve the use of a contrast agent to improve image quality.[9][5]

PET scans, or positron emission tomography scans, are another type of imaging test that can help doctors determine whether cancer has spread outside the colon. A PET scan involves injecting a small amount of radioactive sugar into your bloodstream. Cancer cells, which use more energy than normal cells, absorb more of this sugar and appear as bright spots on the scan. PET scans are particularly useful for deciding if surgery is an option when cancer has spread to other organs.[9]

Ultrasound imaging may also be used, particularly for examining the liver or the pelvis. This test uses sound waves to create images of the inside of your body and is non-invasive and painless. Ultrasound can help identify tumors and assess their characteristics.[5]

In some cases, doctors may also order a bone scan if they suspect that cancer has spread to your bones. This test involves injecting a small amount of radioactive material into your vein, which travels to your bones and helps highlight areas where cancer may be present.[5][6]

⚠️ Important
Imaging tests are safe and commonly used, but they do involve exposure to radiation (in the case of CT and PET scans) or the use of contrast dyes. If you have concerns about these tests, such as allergies to contrast materials or kidney problems, make sure to discuss them with your healthcare team before the procedure. They can adjust the testing plan or take precautions to keep you safe.

Biopsy

A biopsy is a procedure in which a small sample of tissue is removed from your body and examined under a microscope in a laboratory. This is the most definitive way to confirm that cancer is present and to determine what type of cancer it is. For colon cancer, the tissue sample is often collected during a colonoscopy, a procedure in which a flexible tube with a camera is inserted through your rectum to examine the inside of your colon. If imaging tests show a suspicious mass in another organ, such as the liver or lung, your doctor may perform a biopsy of that area as well.[9][5]

Once the tissue sample is obtained, laboratory tests are performed to examine the cells and determine if they are cancerous. Additional tests on the cancer cells can reveal important information about genetic changes, or mutations, that are present. This information helps your doctors understand how aggressive the cancer is and guides decisions about which treatments are most likely to work for you.[9]

Blood Tests

Blood tests are another important part of diagnosing and monitoring metastatic colon cancer. One of the most commonly used blood tests is the carcinoembryonic antigen (CEA) test. CEA is a protein that is produced by some colon cancer cells, and elevated levels of CEA in the blood can indicate the presence or progression of cancer. This test is particularly useful for monitoring how well treatment is working or for detecting if cancer has returned after treatment. However, not all colon cancers produce CEA, so a normal result doesn’t always mean cancer is absent.[9][5]

Other blood tests may be used to check your overall health and organ function, especially if you are preparing for treatment. These tests can assess your liver and kidney function, blood cell counts, and other important markers.[5]

Molecular and Genetic Testing

Some colon cancers have specific gene changes, or mutations, that affect how the cancer grows and how it responds to treatment. Molecular and genetic testing involves analyzing the cancer cells in a laboratory to look for these mutations. Identifying these genetic features is important because certain treatments only work for cancers with specific mutations. For example, some targeted therapies are designed to attack cancer cells with particular genetic changes, while immunotherapy may be more effective for cancers with certain characteristics.[9]

Your doctor may refer to this process as biomarker testing. Understanding your cancer’s biomarker status helps your medical team personalize your treatment plan and choose therapies that are most likely to be effective for your specific type of cancer.[5]

Colonoscopy and Other Endoscopic Procedures

A colonoscopy is not only used to collect tissue samples but also to examine the inside of your colon directly. During this procedure, your doctor can see if the cancer has returned to your intestine or if there are new areas of concern. The procedure is performed under sedation, so you won’t feel pain during the test.[5]

Other procedures, such as sigmoidoscopy or upper endoscopy, may be used depending on where the cancer is located and what symptoms you are experiencing. These procedures allow doctors to look inside different parts of your digestive system using a flexible tube with a camera.[5]

Diagnostics for Clinical Trial Qualification

If you are considering enrolling in a clinical trial, you will need to undergo specific diagnostic tests to determine if you are eligible. Clinical trials are research studies that test new treatments or combinations of treatments to see if they are safe and effective. These trials often have strict criteria about who can participate, and diagnostic tests are used to confirm that you meet these requirements.[5]

The types of tests required for clinical trial qualification can vary depending on the specific trial, but they typically include many of the same tests used for standard diagnosis and monitoring. Imaging tests such as CT scans, MRI scans, or PET scans are commonly required to assess the extent of cancer spread and to measure the size of tumors. These baseline measurements are important because they allow researchers to track how well the treatment is working over time.[9]

Biomarker testing is often a key requirement for clinical trial enrollment. Many trials are designed to test treatments that target specific genetic mutations or other characteristics of cancer cells. For example, a trial might only be open to patients whose tumors have a particular mutation, such as changes in genes called KRAS, BRAF, or microsatellite instability (MSI). Your medical team will test your cancer to see if it has the required biomarkers before you can be enrolled.[9]

Blood tests are also commonly required to check your overall health and organ function. Clinical trials need to ensure that participants are healthy enough to tolerate the experimental treatment, so tests that measure liver function, kidney function, and blood cell counts are often performed. The CEA test may also be used to monitor cancer progression during the trial.[9]

A biopsy may be required at the start of a clinical trial to confirm your diagnosis and to collect tissue samples for research purposes. In some cases, additional biopsies may be performed during the trial to see how the cancer is responding to treatment. These tissue samples help researchers learn more about how the treatment affects cancer cells.[9]

It’s important to discuss clinical trial options with your doctor if you are interested in participating. Your doctor can help you understand which trials might be suitable for you and what tests you will need to complete to qualify. Keep in mind that not everyone will be eligible for every trial, but there are many different trials available, and your medical team can help you find one that matches your situation.[5]

⚠️ Important
Clinical trials offer access to cutting-edge treatments that are not yet widely available. While there are potential benefits, there are also risks and unknowns. Take time to ask questions, read the informed consent documents carefully, and discuss the decision with your family and healthcare team. You can leave a clinical trial at any time if you change your mind or if the treatment causes unacceptable side effects.

Prognosis and Survival Rate

Prognosis

The prognosis for metastatic colon cancer depends on many factors, including where the cancer has spread, how much cancer is present in the body, the specific genetic characteristics of the cancer, and your overall health. Treatment for metastatic colon cancer focuses on controlling the disease, relieving symptoms, and improving quality of life. While metastatic colon cancer is generally not curable, treatments such as chemotherapy, targeted therapy, immunotherapy, and surgery can help keep the cancer under control for a period of time. In a small number of cases where cancer has spread to only one area, such as the liver or lungs, and can be completely removed with surgery, long-term control or even cure may be possible.[5][18]

Factors that can affect prognosis include the location and number of metastases, whether the cancer can be surgically removed, how well the cancer responds to treatment, and whether the cancer has certain genetic mutations that make it more or less responsive to specific therapies. Your medical team will use all of this information, along with the results of your diagnostic tests, to give you a better understanding of what to expect and to develop a treatment plan tailored to your needs.[5]

Survival Rate

Metastatic colorectal cancer has a five-year survival rate of approximately 14 percent. This means that about 14 out of every 100 people diagnosed with metastatic colorectal cancer are still alive five years after their diagnosis. It’s important to remember that survival statistics are based on large groups of people and reflect averages. Every person’s situation is unique, and many factors can influence individual outcomes. Advances in treatment, including new targeted therapies and immunotherapies, are helping some people live longer and with better quality of life than was possible in the past.[2]

Survival rates can also vary depending on whether the cancer has spread to one organ or multiple organs. For example, people with cancer that has spread to only one area may have better outcomes, especially if that cancer can be removed with surgery. Your doctor can provide more specific information about your prognosis based on your individual situation and test results.[7]

Ongoing Clinical Trials on Colon cancer metastatic

  • Study Comparing Dostarlimab with CAPEOX and CAPEOX Alone for Patients with Untreated Stage III Colon Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Belgium Italy Spain
  • Study on Botensilimab Alone and with Balstilimab or Drug Combination for Patients with Refractory Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Belgium France Italy Spain

References

https://www.mayoclinic.org/diseases-conditions/stage-4-colon-cancer/symptoms-causes/syc-20584697

https://pmc.ncbi.nlm.nih.gov/articles/PMC10365888/

https://www.cancer.gov/news-events/cancer-currents-blog/2019/early-metastasis-colorectal-cancer

https://www.mskcc.org/cancer-care/types/colon/treatment/metastases

https://www.columbiadoctors.org/health-library/condition/colorectal-cancer-metastatic-or-recurrent/

https://www.cancerresearchuk.org/about-cancer/bowel-cancer/metastatic/symptoms

https://colorectalcancer.org/basics/stages-colorectal-cancer/stage-iv

https://my.clevelandclinic.org/health/diseases/14501-colorectal-colon-cancer

https://www.mayoclinic.org/diseases-conditions/stage-4-colon-cancer/diagnosis-treatment/drc-20584817

https://www.mskcc.org/cancer-care/types/colon/treatment/metastases

https://www.cancer.org/cancer/types/colon-rectal-cancer/treating/by-stage-colon.html

https://www.uchicagomedicine.org/cancer/types-treatments/colorectal-cancer/metastatic-colorectal-cancer-treatment

https://www.cancerresearchuk.org/about-cancer/bowel-cancer/metastatic/treatment/treatment-options

https://www.mdanderson.org/cancer-types/colon-cancer/colon-cancer-treatment.html

https://www.mayoclinic.org/diseases-conditions/stage-4-colon-cancer/diagnosis-treatment/drc-20584817

https://www.cancer.org/cancer/types/colon-rectal-cancer/after-treatment/living.html

https://www.aacr.org/patients-caregivers/survivor-journeys/living-in-the-moment-with-metastatic-colon-cancer/

https://www.cancerresearchuk.org/about-cancer/bowel-cancer/metastatic/coping-support

https://colorectalcancer.org/basics/stages-colorectal-cancer/stage-iv

https://www.fruzaqla.com/metastatic-colorectal-cancer

https://www.bowelcanceruk.org.uk/news-and-blogs/this-is-bowel-cancer-blog/what-i-wish-i-had-been-told-when-i-was-diagnosed-at-stage-4/

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

What is the difference between a CT scan and an MRI scan?

A CT scan uses X-rays and computer technology to create cross-sectional images of your body, while an MRI scan uses powerful magnets and radio waves to produce detailed images of soft tissues. Both tests are useful for detecting metastatic colon cancer, but MRI scans can provide more detailed images of certain organs, such as the liver and brain.

Will I need a biopsy if imaging tests show cancer has spread?

In many cases, yes. A biopsy involves removing a small sample of tissue to examine under a microscope, and it is the most definitive way to confirm that cancer is present and to determine what type of cancer it is. If imaging tests show a suspicious mass in an organ like the liver or lung, your doctor may perform a biopsy of that area.

What is biomarker testing and why is it important?

Biomarker testing involves analyzing your cancer cells in a laboratory to look for specific genetic mutations or characteristics. This testing is important because it helps doctors choose treatments that are most likely to work for your specific type of cancer. Some treatments only work for cancers with certain mutations, so knowing your biomarker status helps personalize your treatment plan.

How often will I need diagnostic tests after starting treatment?

The frequency of follow-up diagnostic tests depends on your individual situation and treatment plan. Your doctor will likely order imaging tests and blood tests at regular intervals to monitor how well the treatment is working and to check for any signs that the cancer is growing or spreading. These tests help your medical team adjust your treatment if needed.

Can metastatic colon cancer be detected early?

Metastatic colon cancer means that the disease has already spread from the colon to other parts of the body, so it is considered an advanced stage. However, research has shown that cancer cells can spread very early in the disease process, sometimes before the original tumor is large enough to be found by screening tests. This is why regular screening and follow-up after treatment are so important.

🎯 Key Takeaways

  • Metastatic colon cancer is diagnosed using a combination of imaging tests, biopsies, blood tests, and genetic testing to determine where the cancer has spread and guide treatment.
  • CT scans and MRI scans are the main imaging tests used to detect cancer spread, while PET scans help decide if surgery is an option.
  • A biopsy is the most definitive way to confirm cancer and determine its type, and tissue samples can reveal important genetic information about your cancer.
  • The CEA blood test can help monitor cancer progression, but not all colon cancers produce this protein.
  • Biomarker testing identifies genetic mutations in your cancer that can help doctors choose the most effective treatments for your specific situation.
  • Clinical trials may require specific diagnostic tests to confirm eligibility, including imaging, biomarker testing, and biopsies.
  • Metastatic colorectal cancer has a five-year survival rate of about 14 percent, but advances in treatment are helping some people live longer with better quality of life.
  • Colorectal cancer can spread very early in its development, sometimes years before the original tumor is detectable by screening tests.